Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

Long-term Anticoagulation After Unprovoked VTE: New Insights

Shelley Wood

September 13, 2021

News Daily News

FDA Approves Dabigatran for VTE in Children

Shelley Wood

June 22, 2021

News Daily News

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

Caitlin E. Cox

June 14, 2021

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Daily News

Study Affirms Thrombotic Risk in COVID-19

Todd Neale

October 01, 2020

News Daily News

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Yael L. Maxwell

July 21, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

Michael O'Riordan

April 29, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

News Daily News

Automated Email Reminders May Boost IVC Filter Retrieval, Cut Complications

Todd Neale

October 23, 2018

News Daily News

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

L.A. McKeown

October 18, 2018

News Daily News

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

Michael O'Riordan

February 21, 2018

News Daily News

Registry Study Makes Case Against Vena Cava Filter Use in Trauma Patients, but Experts Say Not So Fast

Yael L. Maxwell

May 10, 2017

News Daily News

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Caitlin E. Cox

November 17, 2016

Advertisement

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

TCTMD’s Top 10 Most Popular Stories for September 2023

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Long-term Anticoagulation After Unprovoked VTE: New Insights

FDA Approves Dabigatran for VTE in Children

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Study Affirms Thrombotic Risk in COVID-19

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

FDA Gives Rivaroxaban Another VTE-Related Indication

Automated Email Reminders May Boost IVC Filter Retrieval, Cut Complications

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

Registry Study Makes Case Against Vena Cava Filter Use in Trauma Patients, but Experts Say Not So Fast

Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content